Term ends Mar 12, 2039 · Medium confidence
20-year base term ends Mar 12, 2039
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,370,803), so the cap could be lower.
Mar 12, 2019
Mar 12, 2039
Oct 14, 2025
This patent's term runs 96 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2019, when application 16/299,996, the earliest non-provisional in its chain, was filed (this one was filed Apr 20, 2022) | Mar 12, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +96 days, USPTO patent term adjustment record | Jun 16, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,370,803, US 11,787,796, US 12,065,448, US 12,221,441) | capped to Mar 12, 2039 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 12, 2039 | Medium confidence |
This family
| US 10,730,874 | In force Mar 2039 | Mar 2039 |
| US 11,352,356 | In force Mar 2039 | Mar 2039 |
| US 12,441,724 | this patent Mar 2039 | Mar 2039 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 2, 2022 Reel 60979, frame 113 | Fink, Sarah Jocelyn | Bioduro LLC | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 188 | Rae, Alastair; Ellard, John Mark | Charles River Discovery Research Services UK Limited | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 211 | Papaioannou, Nikolaos; Miller, Thomas Allen; Shipps, Gerald Wayne, JR.; Travins, Jeremy Mark; Ehmann, David Edward | Shire Human Genetic Therapies, Inc. | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 247 | Bioduro LLC | Shire Human Genetic Therapies, Inc. | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 293 | Charles River Discovery Research Services UK Limited | Charles River Laboratories, Inc. | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 299 | Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical Company Limited | Assignment of Assignor's Interest |
| Sep 2, 2022 Reel 60979, frame 360 | Charles River Laboratories, Inc. | Shire Human Genetic Therapies, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,370,803, US 11,787,796, US 12,065,448, US 12,221,441.